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Abstract
Background: Fluid resuscitation is a crucial therapy for sepsis, and the use of
balanced fluids and/or isotonic albumin may improve patient survival. We have
previously demonstrated that resuscitation with normal saline results in increased
hepatic leukocyte recruitment in a murine model of sepsis. Given that clinical
formulations of albumin are in saline, our objectives were to develop a novel
balanced electrolyte solution specifically for sepsis and to determine if
supplementing this solution with albumin would improve the inflammatory response
in sepsis.
Methods: We developed two novel buffered electrolyte solutions that contain
different concentrations of acetate and gluconate, named Seplyte L and Seplyte H,
and administered these solutions with or without 5% albumin. Normal saline with or
without albumin and Ringer’s lactate served as controls. Sepsis was induced by cecal
ligation and puncture (CLP), and the liver microvasculature was imaged in vivo at 6 h
after CLP to quantify leukocyte recruitment. Hepatic cytokine expression and plasma
cell-free DNA (cfDNA) concentrations were also measured.
Results: Septic mice receiving either Seplyte fluid showed significant reductions in
hepatic post-sinusoidal leukocyte rolling and adhesion compared to normal saline.
Hepatic cytokine concentrations varied in response to different concentrations of
acetate and gluconate in the novel resuscitation fluids but were unaffected by
albumin. All Seplyte fluids significantly increased hepatic TNF-α levels at 6 h
compared to control fluids. However, Seplyte H exhibited a similar cytokine profile to
the control fluids for all other cytokines, whereas mice given Seplyte L had
significantly elevated IL-6, IL-10, KC (CXCL1), and MCP-1 (CCL2). Plasma cfDNA was
generally increased during sepsis, but resuscitation fluid composition did not
significantly affect cfDNA concentrations.
Conclusions: Electrolyte concentrations and buffer constituents of resuscitation fluids
can modulate hepatic cytokine production and leukocyte recruitment in septic mice,
while the effects of albumin are modest during early sepsis. Therefore, crystalloid fluid
choice should be an important consideration for resuscitation in sepsis, and the effects
of fluid composition on inflammation in other organ systems should be studied to
better understand the physiological impact of this vital sepsis therapy.
Keywords: Sepsis, Resuscitation fluid, Albumin, Leukocyte recruitment, Cytokine,
Chemokine, Cell-free DNA, Cecal ligation and puncture, Intravital microscopy
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Background
Sepsis is characterized by severe inflammation along with organ dysfunction resulting
from a dysregulated host response to infection and requires timely fluid resuscitation
to improve patient survival. The main treatment regimen for patients with sepsis in-
volves restoring microvascular blood flow using intravenous fluid resuscitation within
6 h of patient presentation, identifying and eliminating the source of infection by ad-
ministering appropriate antimicrobials, and providing supportive care for organ dys-
function [1]. Although fluid resuscitation is a key component of sepsis treatment, the
ideal choice of intravenous fluid for early resuscitation of septic patients remains
controversial [2, 3].
Traditional crystalloid fluids, such as normal saline and Ringer’s lactate, remain as
the most commonly used fluids by intensivists to manage sepsis and early septic shock
[4, 5]. Colloid fluids, consisting of proteins or starches suspended in electrolyte solu-
tions, have also been used for resuscitation of patients with sepsis. With evidence that
colloid fluids containing hydroxyethyl starches increase the risk of acute kidney injury
and mortality in critically ill patients [6, 7], and uncertainty about the safety of gelatins
[8], clinicians are now limited to albumin. The Surviving Sepsis Campaign guidelines
currently recommend crystalloids as first-line therapy and colloid solutions containing
albumin when excessive fluid resuscitation is required [1]. While current evidence sug-
gests that resuscitation with isotonic albumin does not cause harm, the question of
benefit remains contested [9–13]. Albumin is typically suspended in saline-based solu-
tions containing 109–137 mM concentrations of chloride [Bram Rochwerg, personal
communication], which may potentiate hyperchloremic acidosis. Indeed, normal saline
has been linked to hyperchloremic metabolic acidosis during large-volume resuscitation
[14]. The fact that commonly used resuscitation fluids may have serious adverse effects
justifies the need to investigate how traditional fluids compare to emerging balanced
fluids, electrolyte solutions containing ion and buffer concentrations that closely resem-
ble those of healthy plasma [15–19]. Current evidence suggests that resuscitation with
balanced fluids may reduce the risk of mortality in patients with sepsis [11, 20], but the
physiological mechanisms involved are unclear.
It is clear that all resuscitation fluids are not equal and an optimized fluid is needed
for use in sepsis treatment. We previously demonstrated that resuscitation fluid com-
position has dramatic effects on hepatic leukocyte recruitment in an animal model of
early sepsis [21, 22]. Since the liver is central to the inflammatory response in sepsis,
and hepatic dysfunction has been associated with long-term mortality from septic
shock [23], we focused on assessing the inflammatory state of the hepatic microvascula-
ture in response to various crystalloids, colloids, and balanced resuscitation fluids dur-
ing sepsis. To accomplish this, we developed two novel balanced fluids that contain ion
concentrations similar to plasma and are buffered with gluconate in addition to either
lower or higher concentrations of acetate, named Seplyte L or H, respectively. We
tested these novel solutions with and without the addition of albumin and compared
them to traditional fluids in a mouse model of early sepsis induced by cecal ligation
and puncture (CLP). The inflammatory response was assessed using intravital micros-
copy of the liver microcirculation and hepatic cytokine concentrations, along with
measurement of plasma cell-free DNA (cfDNA)—a biomarker that indicates poor prog-
nosis when elevated in sepsis [24, 25]. We hypothesized that fluid resuscitation with
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the novel Seplyte fluids would reduce the hepatic inflammatory response during early
sepsis and that supplementing these fluids with albumin would enhance this reduction.
Methods
Novel buffered electrolyte solutions
Seplyte L and Seplyte H solutions were prepared in 1 L of Millipore water with the
compounds and concentrations listed in Table 1. Once dissolved and pH adjusted to 7,
the solutions were filter sterilized using Millipore Stericup and Steritop Express Plus
0.22 μm filters.
A stock solution of sodium acetate and sodium gluconate was prepared at 10 mg/mL
with the ratio of molecular weights of each ion in the compound taken into account. A
10 mg/mL stock solution of sodium sulfate was prepared for use as the internal stand-
ard. Calibration standards were prepared in the range of 0.6–50 μg/mL, with threefold
dilutions between each standard. Samples of Seplyte L and Seplyte H were diluted by a
factor of 100 for optimal detection. Each calibration standard and samples contained a
constant concentration of internal standard at 10 μg/mL.
Electrospray ionization mass spectrometry was used to examine the stability of the
novel electrolyte solutions by examining the concentrations of acetate and gluconate
ions over time. The Micromass Quattro Ultima LC-ESI/APCI Triple Quadrupole Mass
Spectrometer was used for all measurements. Injections of 10 μL were made using a
syringe into the six-port injector equipped with a 10-μL sample loop. The sample was
then carried into the ionization chamber of the mass spectrometer by the mobile phase
(water/methanol, 50:50) at 50 μL/min. The instrument was set to a source temperature
of 800 °C and dissolution temperature of 2100 °C, with cone gas flowing at approxi-
mately 130 L/h and dissolution gas at 900–1200 L/h. All analyses were made in nega-
tive ion mode, with a capillary voltage of 3.00 kV applied at the tip and cone voltage set
to 35 V. Blanks were injected between samples to minimize carry-over. Selected ion










NaCl 5.581 Mg2+ 1.25
NaC6H11O7 (sodium gluconate) 4.035 C6H11O7
− 18.5
NaCH3CO2 (sodium acetate) 2.297 CH3COO
− 28
Ca2+ 2.5





NaCl 5.611 Mg2+ 1.25
NaC6H11O7 (sodium gluconate) 2.618 C6H11O7
− 12
NaCH3CO2 (sodium acetate) 2.789 CH3COO
− 34
Ca2+ 2.5
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monitoring was chosen as the scanning method, and smoothing algorithms were ap-
plied to the data to allow the area under the curve to be integrated, reflecting the
strength of the signal. The responses of the target analytes were measured in terms of
the internal standard response. The equation of the calibration curve was applied to
the relative values to determine the concentration of the acetate and gluconate ions in
solution. Concentration analyses were performed for one batch at approximately
3 months after the date of preparation and another batch at approximately 1 year. Data
is reported for the 1-year analysis (Table 2). Various storage conditions were examined
to determine long-term stability when stored in plastic or glass and under light or
darkness.
Animals
Wild-type, Helicobacter hepaticus-negative, C57BL/6 male mice were purchased from
Taconic Laboratories (Georgetown, NY, USA) for the experiments. All mice were
housed under pathogen-free conditions and had access to standard rodent food and
water ad libitum. Experiments were performed on mice between 7 and 10 weeks of age.
This study received approval by the Animal Research Ethics Board at McMaster
University and met all criteria outlined by the Canadian Council on Animal Care.
Preliminary fluid studies in endotoxemia
The acute hepatic response to normal saline, Ringer’s lactate, and the two novel Seplyte
solutions was assessed through intravital microscopy of the mouse liver at 4 h after in-
jection of lipopolysaccharide (LPS) or control (see Additional file 1).
Cecal ligation and puncture
Polymicrobial sepsis was induced by CLP as previously described by Baker et al. [26],
with the following modifications: all animals received subcutaneous analgesic (bupre-
norphine; 0.05 mg/kg) and underwent laparotomy while under isoflurane anesthesia
(Baxter, Mississauga, ON, Canada). Using sterile technique, an intravenous line (poly-
ethylene 10 mm, VWR Canada, Mississauga, ON, Canada) was introduced by cutdown
into the right internal jugular vein and tunneled subcutaneously to the back of the
Table 2 Concentrations of gluconate and acetate in novel Seplyte solutions stored under various
conditions, as measured by mass spectroscopy





Prepared fresh 38.64 12.02
Plastic light exposed 36.64 12.80
Plastic dark 40.04 14.64
Glass light 37.19 14.43





Prepared fresh 23.12 15.35
Plastic light exposed 112.48a 19.66
Plastic dark 26.15 17.56
Glass light 25.48 18.92
Glass dark 27.14 19.29
aMarkedly different from expected concentration
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neck. A 1-cm portion of the distal cecum was then exteriorized, ligated, and punctured
once with an 18-gauge needle, and a small amount of fecal matter was extruded. The
cecum was then replaced into the abdominal cavity, and the incision was sutured to
close the muscle and skin independently. Sham-operated mice were treated identically
except for the ligation and puncture of the cecum. All animals were resuscitated ac-
cording to the experimental design with an injection through the jugular vein catheter.
The catheter was then flushed with 20 μL of heparinized saline to prevent blood from
clotting and occluding the catheter.
Experimental design
Sham and CLP animals were randomized to receive one of the following resuscita-
tion fluids: normal saline, Ringer’s lactate, normal saline with 5% albumin (w/v;
Baxter), Seplyte L, Seplyte L with 5% albumin, Seplyte H, or Seplyte H with 5% al-
bumin. Solutions containing 5% albumin were prepared using endotoxin-free albu-
min from Amsbio (Lake Forrest, CA, USA). Fluids were administered intravenously
immediately following surgery and 4 h later. The crystalloid solutions (without al-
bumin) were given as 0.5-mL boluses at each time point, based on the dosing of
20 mL/kg used in clinical practice. The colloid solutions (containing albumin) were
given as 0.125-mL injections. The ratio of 1:4 colloid to crystalloid is based on the
oncotic properties of these solutions [27].
Intravital microscopy
The hepatic microcirculation was examined using trans-illumination intravital micros-
copy 6 h after inducing sepsis, as previously described [21]. All mice were anesthetized
with an intraperitoneal injection of ketamine (200 mg/kg) and xylazine (10 mg/kg). The
abdomen was re-opened with a midline incision extending near the costal margin. Mice
were then placed in a left lateral position on a Plexiglas microscope stage with the left
lobe of the liver exteriorized and covered with plastic wrap (Saran Wrap) in order to
prevent dehydration and movement from respiration. Body temperatures were main-
tained by the use of an infrared heat lamp and a heated water-circulating jacket built
into the stage.
Hepatic sinusoids and post-sinusoidal venules were visualized by intravital micros-
copy (Zeiss Inverted Axiovert S100, Toronto, ON, Canada). Blood flow through the
microcirculation was captured with an attached camera (Newvicon DAGE- MTI,
Michigan City, IN, USA) and viewed on a monitor (Panasonic CT-2086YD, Missis-
sauga, ON, Canada). The images were recorded using a DVD recorder (Panasonic
DMR-EH55) for offline analysis. Within each field of view, one post-sinusoidal venule
or approximately 6–10 sinusoids were observed. The number of adherent and rolling
leukocytes was quantified during video playback analysis. Leukocytes were considered
rolling if tethering to a given venule with a torsional motion was observed. Adherent
leukocytes became immobilized along the endothelial wall and remained stationary for
a minimum of 30 s. Vessel images were recorded at time 0 and 10 min later, for the
duration of 2 min at each time point, to obtain an average of leukocytes per minute per
field of view (160 × 200 μm).
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Sample collection
Following intravital microscopy, animals were sacrificed via cardiac puncture followed
by cervical dislocation. Blood was collected from the left ventricle with a sodium-
citrated syringe and processed within 30 min. The blood was centrifuged at 1500×g and
the plasma portion stored at −80 °C for further cfDNA analysis. Remaining whole blood
was smeared onto a slide for leukocyte differential counts using a compound light
microscope. Slides were stained for differential leukocyte identification using a Hema-
color Staining Set (EMD Millipore, Gibbstown, NJ, USA). The leukocyte differential
values were based on counting 100 cells per slide to determine the percentage of neu-
trophils, lymphocytes, monocytes, and eosinophils. Whole blood was also mixed with
3% acetic acid and 1% crystal violet dye (5:44:1, blood/acetic acid/dye ratio) to deter-
mine total leukocyte counts using a hemocytometer. Absolute leukocyte differentials
were calculated by multiplying the proportion of each type of leukocyte by the total
leukocyte count. Lastly, tissue samples of the liver were collected, snap frozen in liquid
nitrogen, and stored at −80 °C for cytokine assays.
Quantification of plasma cell-free DNA
For isolation of cfDNA from mouse plasma, the Qiagen QIAamp DNA Mini Blood
Mini Kit was used according to the manufacturer’s instructions (Qiagen, Valencia, CA,
USA) after spinning plasma at 16,800×g for 10 min. A spectrophotometer (Eppendorf
BioPhotometer Plus, Hamburg, Germany) was used to quantify levels of cfDNA. The
optical density (OD) reflects the amount of DNA present and was measured at excita-
tion and emission wavelengths of 260 and 280 nm, respectively. The OD/260 nm values
were converted to nanogram per microliter using the conversion of 1 OD/260 nm =
50 ng/μL DNA. A standard calibration curve was obtained using known ssDNA con-
centrations (UltraPure Salmon Sperm DNA, ThermoFisher Scientific, Burlington, ON,
Canada) ranging from 0 to 10 mg/mL and was used to confirm the accuracy of cfDNA
concentrations calculated using the OD method.
Cytokine profiling
A Bio-Plex Cell Lysis Kit (Bio-Rad Laboratories, Mississauga, ON, Canada) was used to
prepare liver samples for cytokine assays according to the manufacturer’s instructions.
Homogenized samples were centrifuged at 4500×g for 10 min, and the supernatant was
collected and frozen at −80 °C. A custom Mouse 7-Plex Cytokine Assay (Bio-Plex Pro
Assay) was designed to measure IL-1β, IL-6, IL-10, IL-17, TNF-α, MCP-1 (CCL2), and
KC (CXCL1) in liver tissue lysates. Homogenized liver supernatant was prepared ac-
cording to instructions, and samples were analyzed on a Bio-Plex Luminex 200 System
at 635- and 532-nm wavelengths using Bio-Plex Manager 6.0 software. To determine
the concentration of each analyte per milligram of total hepatic protein, the mass of
each analyte measured through the Bio-Plex assay was divided by the corresponding
Bradford Protein Assay value for the sample.
Statistical analyses
Statistical analyses were performed using GraphPad Prism 5.0 (La Jolla, CA, USA).
Data are presented as mean ± standard error of the mean (SEM). Data obtained from
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multiple groups were analyzed using one-way analysis of variance (ANOVA) followed
by Bonferroni post hoc tests. Differences between groups were considered to be statisti-
cally significant at p < 0.05.
Results
Novel resuscitation fluids
Both of the novel Seplyte fluids remained stable under a variety of storage conditions
over the course of 1 year, except for Seplyte H stored in plastic and exposed to light
(Table 2).
Hepatic leukocyte recruitment in response to resuscitation with novel Seplyte fluids
To compare the effects of traditional crystalloids and novel balanced Seplyte fluids on
leukocyte recruitment in vivo, we examined the hepatic microcirculation using intravi-
tal microscopy. Leukocyte rolling in post-sinusoidal venules of mice undergoing CLP
was similar to that observed in corresponding sham groups (Fig. 1a). However, normal
saline resuscitation significantly increased post-sinusoidal leukocyte rolling compared
to all other fluid treatments. Leukocyte adhesion in hepatic post-sinusoidal venules was
significantly elevated in septic mice relative to shams regardless of which traditional or
balanced crystalloid was administered (Fig. 1b). Furthermore, septic mice receiving nor-
mal saline experienced significantly more post-sinusoidal adhesion than septic mice re-
ceiving any other crystalloid fluid. Mice subjected to CLP also had significantly
increased sinusoidal leukocyte adhesion compared to sham controls for each crystalloid
fluid, although there were no significant differences between fluids (Fig. 1c). Sinusoidal
blood flow was significantly decreased in septic mice compared to shams for all crystal-
loid fluid treatments but also did not significantly differ between fluids (Fig. 1d). Taken
together, these results demonstrate that the novel Seplyte fluids have similar effects to
those of Ringer’s lactate on leukocyte recruitment in the liver during sepsis. On the
other hand, leukocyte recruitment in the liver is increased in response to normal saline
resuscitation.
Crystalloid fluid composition affects hepatic cytokine production during sepsis
In order to further assess the hepatic inflammatory response to the novel balanced
crystalloid fluids during sepsis, we analyzed hepatic cytokine production in mice sub-
jected to either CLP or sham surgery. Septic mice generally had significantly greater
hepatic cytokine expression compared to sham mice for each resuscitation fluid, but at
this time point, IL-17 was only present in trace amounts (<1 pg/mg hepatic protein) in
all sham and CLP groups (data not shown). Septic mice resuscitated with Seplyte H
produced similar concentrations of hepatic cytokines as mice treated with control fluids
(Fig. 2a–e), with the exception of TNF-α (Fig. 2f ). Interestingly, both Seplyte fluids sig-
nificantly increased TNF-α compared to control fluids, with Seplyte L resulting in sig-
nificantly greater TNF-α concentrations than Seplyte H (Fig. 2f ). Furthermore, septic
mice receiving Seplyte L had the highest hepatic concentrations of all measured cyto-
kines, and these concentrations were significantly different from both control fluids for
all cytokines except IL-1β (Fig. 2a–f ). Since Seplyte L and Seplyte H have variable acet-
ate and gluconate concentrations in the presence of identical concentrations of all other
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constituents, these findings suggest that acetate and gluconate can affect hepatic cyto-
kine production, especially that of TNF-α. Collectively, these results demonstrate that
crystalloid fluid composition can have a dramatic impact on inflammatory cytokine
production in the liver during early sepsis.
Hepatic leukocyte recruitment and cytokine production in response to fluid resuscitation
with albumin
To determine whether addition of albumin to the novel Seplyte fluids could impact in-
flammation in the liver, we first used intravital microscopy to quantify hepatic leukocyte
recruitment in vivo. Leukocyte rolling in the hepatic post-sinusoidal venules was similar
between sham and CLP groups resuscitated with either Seplyte L or H + 5% albumin,
whereas septic mice treated with normal saline + 5% albumin paradoxically had signifi-
cantly decreased rolling compared to sham controls (Fig. 3a). On the contrary, CLP-
induced sepsis resulted in significant increases in post-sinusoidal leukocyte adhesion
relative to sham controls for all fluid treatment groups (Fig. 3b). Furthermore, septic
Fig. 1 Leukocyte recruitment in the hepatic microcirculation in response to resuscitation with novel or
traditional crystalloids. Intravital microscopy was used to measure leukocyte rolling (a) and adhesion (b) in
hepatic post-sinusoidal venules, as well as sinusoidal leukocyte adhesion (c) and blood flow (d) in CLP or
sham mice at 6 h after surgery. All mice were resuscitated with either 20 mL/kg of Ringer’s lactate, normal
saline, or novel Seplyte L or H fluids, in accordance with clinical dosing practice. Fluids were administered
intravenously immediately following surgery and 4 h later. Data are presented as mean ± SEM with n = 6–8
for all groups. ***p < 0.001; asterisk directly above error bar indicates comparison to sham control. CLP cecal
ligation and puncture, RL Ringer’s lactate, NS normal saline, SepL Seplyte L, SepH Seplyte H
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mice resuscitated with either Seplyte L or H containing albumin had significantly re-
duced post-sinusoidal leukocyte adhesion compared to mice treated with normal saline
containing albumin. Similar to hepatic post-sinusoidal venules, leukocyte adhesion in
hepatic sinusoids was significantly increased in response to CLP in all fluid treatment
groups (Fig. 3c). However, hepatic sinusoidal adhesion was greatest in mice treated with
Seplyte H + 5% albumin. Interestingly, despite increases in sinusoidal adhesion which
tend to obstruct blood flow, septic mice treated with Seplyte H + 5% albumin also had
the greatest percentage of flowing sinusoids when compared to either normal saline or
Seplyte L with albumin (Fig. 3d). Since sinusoidal blood flow was significantly de-
creased in response to sepsis for all resuscitation fluids, these findings suggest that the
osmotic effects of albumin are not sufficient to restore sinusoidal blood flow in septic
mice. Overall, the patterns of hepatic leukocyte recruitment in response to fluid resus-
citation with albumin appear similar to those observed in response to the crystalloid
fluids alone (Figs. 1 and 3), though resuscitating with albumin appears to modestly
ameliorate the increases in post-sinusoidal leukocyte adhesion during sepsis (compare
Figs. 1b and 3b). Taken together, these observations suggest that supplementing
Fig. 2 Crystalloid fluid composition influences hepatic cytokine production by septic mice. Concentrations
of MCP-1 (a), KC (b), IL-1β (c), IL-6 (d), IL-10 (e), and TNF-α (f) were measured in mouse livers at 6 h after
CLP. Data are presented as mean ± SEM with n = 5–6 for each group. **p < 0.01, ***p < 0.001. RL Ringer’s
lactate, NS normal saline, SepL Seplyte L, SepH Seplyte H
Patrick et al. Intensive Care Medicine Experimental  (2017) 5:5 Page 9 of 18
resuscitation fluids with albumin has a modest reduction on leukocyte recruitment in
the hepatic microcirculation.
To further assess any effects of albumin on hepatic inflammation, we measured
hepatic concentrations of various pro- and anti-inflammatory cytokines relevant in
sepsis. Similar to our findings in the crystalloid fluids alone (Fig. 2), we observed
significant increases in MCP-1, KC, IL-6, IL-10, and TNF-α, but not IL-1β, in sep-
tic mice resuscitated with Seplyte L + 5% albumin when compared to normal sa-
line + 5% albumin (Fig. 4a–f ). Interestingly, TNF-α remained significantly elevated
for both Seplyte fluids supplemented with albumin in comparison to normal saline
with albumin (Fig. 4f ), with similar concentrations as observed for the crystalloid
fluids alone (Fig. 2f ). The only notable effect of albumin on the hepatic cytokine
profile that we observed in septic mice was a significant decrease in IL-1β in re-
sponse to Seplyte H + 5% albumin (Fig. 4c), which differed from the trends ob-
served for crystalloid fluids alone (Fig. 2c). Therefore, these data suggest that
Fig. 3 Leukocyte recruitment in the hepatic microcirculation in response to resuscitation with colloid
solutions of albumin. Intravital microscopy was used to measure leukocyte rolling (a) and adhesion (b) in
hepatic post-sinusoidal venules, as well as sinusoidal leukocyte adhesion (c) and blood flow (d) in CLP or
sham mice at 6 h after surgery. All mice were resuscitated with either 5 mL/kg of normal saline containing
5% albumin, or novel Seplyte L or H fluids containing 5% albumin, in accordance with clinical dosing practice.
Fluids were administered intravenously immediately following surgery and 4 h later. Data are presented as
mean ± SEM with n = 5–6 for each group. *p < 0.05, **p < 0.01, ***p < 0.001; asterisk directly above error
bar indicates comparison to sham control. CLP cecal ligation and puncture, NS normal saline, SepL
Seplyte L, SepH Seplyte H, 5% Alb 5% albumin
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albumin has a modest effect on hepatic cytokine concentrations only when incor-
porated into the novel Seplyte H fluid.
cfDNA levels
For all resuscitation fluids, cfDNA values trended towards increases in CLP mice com-
pared to the corresponding shams, and these comparisons were significantly different
for Seplyte L with or without albumin, Seplyte H alone, and normal saline with albumin
(Fig. 5a, b). Plasma cfDNA concentrations in septic mice did not significantly differ
among the various crystalloid solutions. Furthermore, adding albumin to each crystal-
loid fluid did not significantly affect cfDNA concentrations, except for modestly de-
creasing cfDNA in septic mice treated with Seplyte H + 5% albumin. Taken together,
these data suggest that cfDNA is generally elevated early in CLP-induced sepsis and its
utility as a biomarker should not be affected by the use of different resuscitation fluids.
Fig. 4 Hepatic cytokine production by septic mice in response to colloid resuscitation fluids. Concentrations
of MCP-1 (a), KC (b), IL-1β (c), IL-6 (d), IL-10 (e), and TNF-α (f) were measured in mouse livers at 6 h after
CLP. Data are presented as mean ± SEM with n = 6 for all groups. *p < 0.05, **p < 0.01, ***p < 0.001. NS normal
saline, SepL Seplyte L, SepH Seplyte H, 5% Alb 5% albumin
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Absolute circulating leukocyte counts
To assess the effects of resuscitation fluid composition on systemic leukocyte counts,
we measured circulating levels of neutrophils, lymphocytes, and monocytes in sham
and septic mice. Circulating neutrophil counts were significantly lower in septic mice
for all fluid treatments, except Seplyte H with albumin, in comparison to shams
(Table 3). Among septic mice, normal saline with albumin resulted in the highest circu-
lating neutrophil counts, which were significantly greater than those found in response
to Seplyte L with albumin. With respect to circulating lymphocytes, there were no sig-
nificant differences between any treatment groups (Table 3). Absolute circulating
monocyte counts were significantly lower in septic mice receiving Ringer’s Lactate, nor-
mal saline, or Seplyte L when compared to sham mice receiving the same fluids, al-
though there were no significant differences between any two fluid treatments in septic
mice (Table 3). Taken together, these findings suggest that resuscitation fluid compos-
ition has minimal to no effect on circulating leukocyte numbers during sepsis.
Fig. 5 Cell-free DNA concentrations measured in septic mice or sham controls resuscitated with either
crystalloid (a) or colloid fluids (b). Data are presented as mean ± SEM with n = 5–7 for each group. *p < 0.05,
**p<0.01. CLP cecal ligation and puncture, RL Ringer’s lactate, NS normal saline, SepL Seplyte L, SepH Seplyte
H, 5% Alb 5% albumin
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Discussion
In this study, we compared the effects of our novel balanced Seplyte solutions with
clinically utilized fluids to determine whether these balanced fluids impact the immune
response that occurs in sepsis. The Seplyte solutions were designed specifically for re-
suscitation in sepsis, and their composition is based upon three principles. First, it is
known that acute kidney injury is a common organ dysfunction associated with sepsis
so patients may have impaired renal K+ clearance [28], and hyperkalemia is a limiting
factor affecting the utility of currently available balanced solutions (such as Ringer’s lac-
tate and Plasma-Lyte) during large-volume resuscitation. With this in mind, the Seplyte
solutions were made free of K+. Second, hyperlactatemia [29] and reduced lactate clear-
ance [30, 31] have been associated with increased mortality in septic patients. Accord-
ingly, the Seplyte solutions are buffered with acetate and gluconate, rather than lactate,
to minimize the lactate load during organ dysfunction, while maintaining pH buffering
and energy production capabilities through metabolism of acetate into bicarbonate [32]
and metabolism of gluconate to produce ATP [33], respectively. This rationale is also
being used by other investigators to study the use of Plasma-Lyte as a resuscitation
fluid in sepsis (NCT02614040 and ANZICS CTG 1415-03). Lastly, these fluids were de-
veloped to satisfy the criteria of a balanced solution and thus contain chloride
Table 3 Mean absolute systemic leukocyte counts (±SEM) in response to resuscitation fluid
treatment in C57BL/6 mice undergoing sham or CLP surgery
Fluid type Sham (×109 cells/L) CLP (×109 cells/L)
A) Neutrophils
Ringer’s lactate 1.22 ± 0.18 0.35 ± 0.04*
Normal saline 1.66 ± 0.15 0.39 ± 0.06*
Normal saline + 5% albumin 2.69 ± 0.17 0.90 ± 0.22*
Seplyte L 1.63 ± 0.11 0.46 ± 0.11*
Seplyte L + 5% albumin 1.83 ± 0.16 0.20 ± 0.05*^
Seplyte H 2.08 ± 0.15 0.68 ± 0.24*
Seplyte H + 5% albumin 1.08 ± 0.23 0.53 ± 0.14
B) Lymphocytes
Ringer’s lactate 2.20 ± 0.18 1.60 ± 0.26
Normal saline 1.83 ± 0.17 1.76 ± 0.15
Normal saline + 5% albumin 1.61 ± 0.22 1.44 ± 0.16
Seplyte L 1.65 ± 0.08 1.92 ± 0.31
Seplyte L + 5% albumin 1.78 ± 0.16 2.56 ± 0.38
Seplyte H 1.49 ± 0.22 2.22 ± 0.38
Seplyte H + 5% albumin 1.08 ± 0.22 1.50 ± 0.21
C) Monocytes
Ringer’s lactate 0.23 ± 0.03 0.07 ± 0.01*
Normal saline 0.27 ± 0.05 0.13 ± 0.03*
Normal saline + 5% albumin 0.19 ± 0.04 0.10 ± 0.03
Seplyte L 0.32 ± 0.06 0.16 ± 0.03*
Seplyte L + 5% albumin 0.28 ± 0.10 0.06 ± 0.26
Seplyte H 0.14 ± 0.05 0.15 ± 0.03
Seplyte H + 5% albumin 0.18 ± 0.06 0.05 ± 0.02
*p < 0.05 compared to sham, ^p < 0.05 compared to normal saline + 5% albumin CLP
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concentrations of 103 mM, which are similar to the concentrations found in plasma in
order to minimize the risk for hyperchloremic acidosis [34, 35].
Upon testing, we found that the Seplyte resuscitation fluids are more beneficial than
normal saline for decreasing leukocyte recruitment in the hepatic microvasculature
during early sepsis in mice. Septic mice resuscitated with these novel balanced fluids
exhibit leukocyte recruitment patterns similar to those seen in mice resuscitated with
Ringer’s lactate. The cytokine profile observed for Seplyte H was also similar to Ringer’s
lactate, with the exception of increased TNF-α in response to the novel fluids. These
findings suggest that Seplyte H may be a suitable crystalloid fluid for resuscitation in
sepsis, though follow-up studies would be required for confirmation. In contrast,
Seplyte L elevated hepatic concentrations of most cytokines, which could potentially
worsen the systemic inflammation that is characteristic of early sepsis. During such in-
flammation, there are increases in systemic neutrophil recruitment [36], which we ob-
served through significantly reduced circulating neutrophil counts in most septic
animals, presumably due to increased migration out of the circulation and into infected
tissues. However, Seplyte L did not dramatically reduce circulating neutrophil counts
compared to other fluids; therefore, it is unlikely that the increases in hepatic cytokines
exacerbated the systemic immune response in our model. It is interesting that Seplyte
L decreased leukocyte recruitment in the liver despite elevating hepatic pro-
inflammatory cytokines. We speculate that simultaneous increases in anti-inflammatory
cytokines could explain this discrepancy as the observed increases in hepatic IL-10 sup-
port this hypothesis, although more anti-inflammatory cytokines would need to be eval-
uated for confirmation.
Whether or not elevated TNF-α is detrimental in sepsis remains controversial. Some
studies show that circulating TNF-α may contribute to hepatocellular dysfunction in early
sepsis [37] and that TNF-α concentrations in plasma are a predictor of mortality in septic
mice [38]. On the other hand, TNF-α blockade using antibodies failed to protect mice
undergoing CLP [39, 40], meanwhile protection was observed following recombinant hu-
man TNF-α injections in septic rats [41]. Importantly, we measured hepatic TNF-α in this
study, rather than plasma concentrations, due to the greater relevance of localized cytokine
concentrations for leukocyte recruitment in the liver. Indeed, Andrejko and Deutschman
found that hepatic, but not circulating, TNF-α modified gene expression in the liver via
paracrine function [42], which suggests that measuring TNF-α in plasma is not sufficient to
determine the concentrations and effects in the liver. It is probable that a balance, with
moderately elevated TNF-α in the tissues while inhibiting excess TNF-α in the circulation,
would maintain efficient leukocyte recruitment to sites of infection while limiting harmful
systemic effects, such as excessive systemic leukocyte recruitment and microvascular leak-
age [43]. If this hypothesis is true, then the hepatic increases in TNF-α observed in re-
sponse to resuscitation with our novel fluids may actually be protective, although additional
studies would be necessary to make such conclusions. Future studies should consider com-
paring the effective concentrations of systemic and local cytokines, in an attempt to recon-
cile the literature about the importance and detriment of TNF-α in early sepsis.
In this study, we have shown that fluid resuscitation with albumin has minimal effects
on hepatic leukocyte recruitment in a murine model of early sepsis. These results contrast
with previous findings that albumin fluid resuscitation can attenuate leukocyte-
endothelial cell interactions in vitro [44] and in vivo [45], in models of septic and
Patrick et al. Intensive Care Medicine Experimental  (2017) 5:5 Page 14 of 18
hemorrhagic shock, respectively. Supplementing crystalloid fluids with albumin also did
not alter circulating neutrophil, monocyte, or lymphocyte counts, which suggests that sys-
temic leukocyte recruitment is unaffected by albumin, and is consistent with the data
from our intravital microscopy experiments demonstrating minimal effects of albumin on
hepatic leukocyte recruitment. Furthermore, albumin did not affect the concentrations of
most hepatic cytokines measured in this study, further supporting that resuscitating with
albumin does not have a significant effect on hepatic inflammation during early sepsis. Re-
suscitation with albumin also did not improve sinusoidal blood flow in this study, which
contrasts with our previous findings that other colloids, namely starches [21] and alpha-1
acid glycoprotein [22], help to restore flow to nearly normal levels in septic mice. This dif-
ferential activity between albumin and other colloids further highlights the need to exten-
sively study the physiological effects of colloids in fluid resuscitation prior to clinical use.
In this study, we also measured cfDNA as a sepsis biomarker [25]. The release of
cfDNA from neutrophils during sepsis has been identified as a protective mechanism to
trap pathogens in so-called neutrophil extracellular traps (NETs) [46]. However, NETs can
also activate endothelial cells and induce collateral tissue damage in the lungs, heart, and
liver [47, 48]. Studies investigating the effects of recombinant human DNase on the effects
of NETs in murine models of sepsis have demonstrated benefits from delayed DNase
treatment [49] and from DNase as an adjunctive treatment to antibiotics [48]. Another
source of cfDNA in sepsis is mitochondrial DNA [50], which was found to contribute to
acute kidney injury and cytokine production in polymicrobial sepsis models [51]. Our re-
sults demonstrate that the type of fluid used for resuscitation does not affect plasma
cfDNA concentrations during early sepsis in mice. Furthermore, the presence or absence
of albumin in these resuscitation fluids did not appear to modulate cfDNA concentrations
during early sepsis. These findings suggest that the choice of resuscitation fluid is unlikely
to affect production of NETs during early sepsis and that cfDNA may be a reasonable bio-
marker to confirm the induction of sepsis in mice undergoing CLP.
There are some limitations to our pilot study comparing traditional and novel resuscita-
tion fluids in early sepsis. We focused on an early time point in order to compare data
with our previous microscopy studies of the liver microcirculation during early sepsis. Fu-
ture studies should extend the time point to gain insight into the effects of fluid resuscita-
tion on leukocyte recruitment, inflammation, and organ injury during later stages of
sepsis. Our study is also limited by its focus on the liver; thus, investigating the effects of
these resuscitation fluids on other organs that become dysfunctional during sepsis, such
as the lungs and kidneys, would be an important avenue for future work.
Conclusions
The novel balanced crystalloid solution of Seplyte H provides some anti-inflammatory
benefit over normal saline by reducing leukocyte recruitment in the hepatic microcircu-
lation with minimal effects on the hepatic cytokine profile, although future studies are
needed to determine whether the increases in hepatic TNF-α are detrimental. Supple-
menting crystalloid fluids with albumin has only modest effects on leukocyte recruit-
ment in the liver microcirculation and does not appear to alter hepatic cytokine
production or circulating leukocyte counts relative to the crystalloids alone. Finally,
plasma cfDNA is unaffected by the choice of resuscitation fluid and thus may be a use-
ful biomarker in experimental studies of fluid resuscitation during sepsis.
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